Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.1111
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2016
Authors
Publisher
Elsevier BV